Stay updated on Relatlimab and Ipilimumab in Advanced Melanoma Clinical Trial
Sign up to get notified when there's something new on the Relatlimab and Ipilimumab in Advanced Melanoma Clinical Trial page.

Latest updates to the Relatlimab and Ipilimumab in Advanced Melanoma Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check17 days agoChange DetectedA new revision entry v3.6.5 is added to the record history, replacing the previous v3.6.4. This reflects a minor update to the page's versioning.SummaryDifference0.1%

- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe history now includes a new revision entry v3.6.4 and removes the previous revision v3.6.3 from the list.SummaryDifference0.1%

- Check52 days agoChange DetectedThe record history now shows a revision tag updated from v3.6.2 to v3.6.3, indicating a minor software update to the page.SummaryDifference0.1%

- Check59 days agoChange DetectedThe page history shows a software release update from v3.6.0 to v3.6.2, indicating a platform version change rather than data changes to the study record.SummaryDifference0.1%

- Check74 days agoChange DetectedAdditions show that no longer looking for participants and the record revision updated to v3.6.0; Deletion removes the previous revision v3.5.5 from the history.SummaryDifference0.4%

- Check81 days agoChange DetectedRevision tag in the page footer updated from v3.5.4 to v3.5.5, signaling a new site release version. This update is metadata-related and does not modify the study record content.SummaryDifference0.1%

Stay in the know with updates to Relatlimab and Ipilimumab in Advanced Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Relatlimab and Ipilimumab in Advanced Melanoma Clinical Trial page.